| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.1200/JCO.1995.13.2.307 |
| P698 | PubMed publication ID | 7844590 |
| P2093 | author name string | B A Kamen | |
| E Frenkel | |||
| O M Colvin | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ifosfamide | Q418560 |
| P304 | page(s) | 307-309 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Ifosfamide: should the honeymoon be over? | |
| P478 | volume | 13 |
| Q33499452 | 6-Day continuous infusion of high-dose ifosfamide with bone marrow growth factors in advanced refractory malignancies |
| Q41548732 | A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/progressive or advanced solid tumors of childhood: a report from the Australia and New Zealand Children's Cancer Study Group |
| Q32117273 | Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites |
| Q80510512 | DNA-binding agents |
| Q34749403 | Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo |
| Q36616877 | Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer |
| Q43964084 | Stem cell toxicity of oxazaphosphorine metabolites in comparison to their antileukemic activity |
| Q35548365 | The development of VAC chemotherapy in Rhabdomyosarcoma: What does one do for an encore? |
| Q33496991 | Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis |
Search more.